CurrentPartnering

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Research Reports By CurrentPartnering

Found 378 publications
Regenerative Medicine Partnering Terms and Agreements US$ 2,995.00 Oct, 2014 1116 pages
Bioinformatics Partnering Terms and Agreements US$ 2,995.00 Oct, 2014 1268 pages
Top 50 Big Pharma Partnering and M&A Deal Trends US$ 3,295.00 Oct, 2014 816 pages
Top 50 Big Biotech Partnering and M&A Deal Trends US$ 2,195.00 Oct, 2014 529 pages
Salix Pharmaceuticals Partnering 2009-2014 US$ 995.00 Sep, 2014 100 pages
Discovery Stage Partnering Terms and Agreements US$ 3,295.00 Sep, 2014 3081 pages
Pharmacyclics Partnering 2009-2014 US$ 995.00 Sep, 2014 100 pages
Jazz Pharmaceuticals Partnering 2009-2014 US$ 995.00 Sep, 2014 100 pages
Hepatitis Partnering 2009-2014 US$ 995.00 Aug, 2014 150 pages
Congestive Heart Failure Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Celgene Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Monsanto Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Galapagos Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Beiersdorf Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Dialysis Partnering 2009-2014 US$ 695.00 Aug, 2014 100 pages
Solid Tumor Partnering 2009-2014 US$ 995.00 Aug, 2014 150 pages
Baxter Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Bacterial Partnering Terms and Agreements US$ 1,795.00 Aug, 2014 801 pages
Lymphoma Partnering 2009-2014 US$ 995.00 Aug, 2014 150 pages
Amgen Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Vertex Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Warner Chilcott Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Obstetrics Partnering 2009-2014 US$ 995.00 Aug, 2014 150 pages
Gastric Cancer Partnering 2009-2014 US$ 695.00 Aug, 2014 150 pages
Immunology Partnering Terms and Agreements US$ 2,995.00 Aug, 2014 1159 pages
Seattle Genetics Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Shire Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
PDL BioPharma Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Purdue Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Orphan Diseases Partnering Terms and Agreements US$ 1,795.00 Aug, 2014 224 pages
Public Health Deals and Alliances of 2013 US$ 1,495.00 Aug, 2014 200 pages
Bladder Cancer Partnering 2009-2014 US$ 695.00 Aug, 2014 150 pages
Irritable Bowel Syndrome Partnering 2009-2014 US$ 695.00 Aug, 2014 100 pages
Novo Nordisk Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Abbott Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Respiratory Deals and Alliances of 2013 US$ 1,495.00 Aug, 2014 200 pages
Ophthalmics Deals and Alliances of 2013 US$ 1,495.00 Aug, 2014 200 pages
Spinal Cord Partnering 2009-2014 US$ 995.00 Aug, 2014 150 pages
Morphosys Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Pneumonia Partnering 2009-2014 US$ 695.00 Aug, 2014 100 pages
Merck & Co Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Kyowa Hakko Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
Neuralgia Partnering 2009-2014 US$ 695.00 Aug, 2014 100 pages
Fresenius Partnering 2009-2014 US$ 995.00 Aug, 2014 100 pages
1 2 3 4 5 ... 8
Skip to top

News & Press-Releases by CurrentPartnering